Acurx Pharmaceuticals, Inc. (ACXP) vs Gelteq Limited Ordinary Shares (GELS)
A side-by-side comparison of Acurx Pharmaceuticals, Inc. and Gelteq Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACXP
Acurx Pharmaceuticals, Inc.
$1.31HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
GELS
Gelteq Limited Ordinary Shares
$0.57HealthcareDelayed quote: Oct 6, 2026, 1:47 PM EDT
Total return — ACXP vs GELS
growth of $100 · dividends reinvested · last 2yACXP -96.5% (-81.4%/yr)GELS -81.5% (-57.0%/yr)GELS compounded faster over this window
Log scale — wide-divergence pair
ACXP GELS
ACXP vs GELS: by the numbers
- •ACXP is the larger company ($6M vs $5M market cap).
- •Both run net losses; ACXP's is the smaller (0.00% vs -4011.86% net margin).
Metrics side by side
Valuation
| Metric | ACXP | GELS |
|---|---|---|
| P/B ratio | 0.69 | 0.55 |
Profitability
| Metric | ACXP | GELS |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -3317.65% |
| Net margin | 0.00% | -4011.86% |
| ROE | -92.08% | -42.05% |
| ROIC | -94.08% | -27.41% |
Growth (annualized)
| Metric | ACXP | GELS |
|---|---|---|
| Total return CAGR (5Y) | -57.41% | N/A |
Go deeper
Dig into the metrics
Acurx Pharmaceuticals ROEGelteq Limited Ordinary Shares ROEAcurx Pharmaceuticals operating marginGelteq Limited Ordinary Shares operating marginAcurx Pharmaceuticals revenue growthGelteq Limited Ordinary Shares revenue growthAcurx Pharmaceuticals free cash flowGelteq Limited Ordinary Shares free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.